PET brain scan for inflammation in MS, fibromyalgia, or CFS
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system, Immune system & allergy clinical trials.
This early-stage study tests an imaging medicine ([F-18]DPA-714) that can help researchers see inflammation in the brain and nervous system. It may help doctors better understand how “inflammation signals” differ across conditions like multiple sclerosis, fibromyalgia, and chronic fatigue syndrome.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old
- You’re either healthy, or have multiple sclerosis, fibromyalgia, or chronic fatigue syndrome
- You must be able to safely do an MRI scan (no MRI contraindications)
- If you could become pregnant: you must not be pregnant or breastfeeding
- In the last month, you can’t have had an infection that required medical care or antibiotics
- You can’t have certain health conditions like HIV/HCV, cancer, blood/clotting disorders, or be in another experimental-therapy trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET-MRI scan to look at brain inflammation in people with relapsing-remitting multiple sclerosis (RRMS). It may help researchers understand how inflammation changes when starting a stronger MS treatment.
This study uses brain scans to look for hidden inflammation in people with multiple sclerosis who have not yet started a strong treatment. It aims to understand how this inflammation affects the disease and to help guide future therapies.
This study uses a new radioactive tracer called [18F]-FZTA during a PET scan to see inflammation in the brain. Researchers want to test this tracer in both healthy adults and people with multiple sclerosis (MS) to see if it can help detect MS activity.
This Phase 1 study tests a special tracer used during MRI and PET scans to look at brain changes in people with multiple sclerosis. It’s mainly aimed at improving how these scans can detect disease-related changes and confirming the tracer works safely.
This early-phase study uses PET and MRI brain scans to better understand brain changes in multiple sclerosis, Alzheimer’s disease, and other neurological or mood conditions. The goal is to test whether these scans can show disease-related differences and guide future treatments.
This trial compares scan results in people with multiple sclerosis or related demyelinating conditions versus people without inflammatory demyelinating diseases. The goal is to better understand what’s happening in the brain and how sex differences may play a role.
Hear when a new Fibromyalgia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.